| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DXCM | Common Stock | Sale | $349,824 | -683 | -5.1% | $512.19 | 12,726 | 03 Aug 2021 | by Trust | F1, F2, F3 |
| transaction | DXCM | Common Stock | Sale | $102,566 | -200 | -1.6% | $512.83 | 12,526 | 03 Aug 2021 | by Trust | F1, F3, F4 |
| transaction | DXCM | Common Stock | Sale | $154,253 | -300 | -2.4% | $514.18 | 12,226 | 03 Aug 2021 | by Trust | F1, F3, F5 |
| transaction | DXCM | Common Stock | Sale | $154,598 | -300 | -2.5% | $515.33 | 11,926 | 03 Aug 2021 | by Trust | F1, F3, F6 |
| transaction | DXCM | Common Stock | Sale | $103,344 | -200 | -1.7% | $516.72 | 11,726 | 03 Aug 2021 | by Trust | F1, F3, F7 |
| transaction | DXCM | Common Stock | Sale | $103,611 | -200 | -1.7% | $518.06 | 11,526 | 03 Aug 2021 | by Trust | F1, F3, F8 |
| transaction | DXCM | Common Stock | Sale | $272,598 | -525 | -4.6% | $519.24 | 11,001 | 03 Aug 2021 | by Trust | F1, F3, F9 |
| transaction | DXCM | Common Stock | Sale | $181,452 | -349 | -3.2% | $519.92 | 10,652 | 03 Aug 2021 | by Trust | F1, F3, F10 |
| holding | DXCM | Common Stock | 16,533 | 03 Aug 2021 | Direct |
| Id | Content |
|---|---|
| F1 | On March 5, 2021, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan. |
| F2 | This transaction was executed in multiple trades at prices ranging from $511.45 to $512.36. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. |
| F3 | Shares are held by the Balo Family Trust U/A/D 4/6/2006, with respect to which the reporting person is a trustee. |
| F4 | This transaction was executed in multiple trades at prices ranging from $512.46 to $513.39. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. |
| F5 | This transaction was executed in multiple trades at prices ranging from $513.59 to $514.43. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. |
| F6 | This transaction was executed in multiple trades at prices ranging from $515.00 to $515.92. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. |
| F7 | This transaction was executed in multiple trades at prices ranging from $516.425 to $517.020. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. |
| F8 | This transaction was executed in multiple trades at prices ranging from $517.600 to $518.515. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. |
| F9 | This transaction was executed in multiple trades at prices ranging from $518.60 to $519.50. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. |
| F10 | This transaction was executed in multiple trades at prices ranging from $519.64 to $520.63. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. |
*EVP Regulatory Strategy Clinical Affairs and Strategic Partnership Development